Detalhe da pesquisa
1.
FLT-PET At 6 Weeks Predicts Response Assessed by CT at 12 Weeks in Melanoma Patients Treated With Pembrolizumab.
Clin Nucl Med
; 45(4): 267-275, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32108700
2.
Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma.
Cancer Res
; 80(5): 1078-1087, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31948941
3.
Prognostic and Predictive Immunohistochemistry-Based Biomarkers in Cancer and Immunotherapy.
Hematol Oncol Clin North Am
; 33(2): 291-299, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30833001
4.
Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma.
Clin Cancer Res
; 25(8): 2494-2502, 2019 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30647081